In a new study, the drug, deucravacitinib, proved to be a safe and more effective treatment for cutaneous lupus erythematosus disease (CLE, lupus skin disease) than two other commonly used therapies, ...

Lupus is a chronic disease that can cause inflammation and pain in any part of the body. It’s an autoimmune disease, which ...

It takes courage to be our genuine selves, writes columnist Candace Semien, who shares a couple powerful prayers for lupus.

Caribou Biosciences has launched a Phase 1 trial testing its CAR T-cell therapy CB-010 for lupus affecting the kidneys and ...

Objective Evaluating the potential role of neuromuscular ultrasonography (NMUS) in assessing optic nerve affection in ...

Prophylactic valaciclovir was effective and prevented herpes zoster in patients with systemic lupus erythematosus receiving ...

She was diagnosed with NPSLE and responded well to steroid treatment, allowing her to discontinue psychiatric medications. Drug-induced lupus (DIL) affects an estimated 15,000 to 30,000 people in ...

Tacrolimus appears to have “synergistic” interactions with mycophenolate mofetil and cyclophosphamide for the treatment of renal involvement in systemic lupus erythematosus, according to ...

People with lupus-related skin problems are more likely to develop heart disease associated with hardening of the a ...

Dr Sudhir Karmacharya, a lupus specialist at the National Center for Rheumatic Diseases (NECRD), stated that lupus is more ...

New research reveals how social determinants of health significantly affect lupus treatment outcomes in Black patients, with ...